151 related articles for article (PubMed ID: 24558024)
21. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
[TBL] [Abstract][Full Text] [Related]
22. Role of high expression of IL-9 in prognosis of CLL.
Chen N; Lv X; Li P; Lu K; Wang X
Int J Clin Exp Pathol; 2014; 7(2):716-21. PubMed ID: 24551294
[TBL] [Abstract][Full Text] [Related]
23. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
[TBL] [Abstract][Full Text] [Related]
24. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
[TBL] [Abstract][Full Text] [Related]
25. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
[TBL] [Abstract][Full Text] [Related]
26. Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma.
Aoyama Y; Kodaka T; Zushi Y; Goto Y; Tsunemine H; Itoh T; Takahashi T
J Clin Exp Hematop; 2018 Mar; 58(1):27-31. PubMed ID: 29415977
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.
Vrbacky F; Smolej L; Vroblova V; Pekova S; Hrudkova M; Cervinka M; Pecka M; Krejsek J; Maly J
Hematology; 2010 Aug; 15(4):210-4. PubMed ID: 20670479
[TBL] [Abstract][Full Text] [Related]
28. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
Menter T; Dirnhofer S; Tzankov A
J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
[TBL] [Abstract][Full Text] [Related]
29. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
30. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.
Van Bockstaele F; Pede V; Janssens A; Callewaert F; Offner F; Verhasselt B; Philippé J
Clin Chem; 2007 Feb; 53(2):204-12. PubMed ID: 17158192
[TBL] [Abstract][Full Text] [Related]
35. Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis.
Späth F; Wibom C; Krop EJ; Johansson AS; Bergdahl IA; Vermeulen R; Melin B
Cancer Res; 2017 Mar; 77(6):1408-1415. PubMed ID: 28108506
[TBL] [Abstract][Full Text] [Related]
36. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
[TBL] [Abstract][Full Text] [Related]
37. Potential role of serum level of soluble CD44 and IFN-γ in B-cell chronic lymphocytic leukemia.
Samy N; Abd El-Maksoud MD; Mousa TE; El-Mezayen HA; Shaalan M
Med Oncol; 2011 Dec; 28 Suppl 1():S471-5. PubMed ID: 20809185
[TBL] [Abstract][Full Text] [Related]
38. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GJ; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR
Blood; 2011 Feb; 117(5):1492-8. PubMed ID: 21048153
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
